Eureka on the web
When you want the answer in the next five minutes.
The agent works the prompt against patents and technical literature, citing every source.
Run your analysis now →Filing growth compares 2021 (5 records) with 2024 (11) — a three-year span. 2024 is the most recent year we treat as complete: publication lags filing by roughly 18 months, so 2025 onwards are still filling in and any growth rate that ends there would understate the field. Top-5 share is the combined record count of the five largest assignees divided by all 479 records in scope (CR5), not by the ranked leaders only.
This dataset tracks patent activity where microbial or recombinant fermentation claims intersect with downstream recovery steps: cell removal, broth clarification, product capture, solvent extraction, phase separation and recovery yield. It spans 479 published records filed between 2015 and mid-2026, drawn from filings classified under fermentation process, bioreactor and microorganism engineering codes (C12P, C12M, C12N). The scope is deliberately narrow to the recovery stage rather than the whole of industrial biotechnology.
Because the search pairs a fermentation term with a recovery or separation term, records here represent inventions that treat downstream processing as part of the claimed invention, not just an incidental step. That makes the set a reasonable proxy for who is actively patenting the harder, less glamorous half of precision fermentation: getting a clean, concentrated product out of a dilute broth at commercial volumes.
Pick a task. Every answer cites the patents behind it.
Two views of the same 479 records: how filing activity has moved year over year, and which IPC subclasses the claims actually sit in. Both use the full record count as their denominator, so class shares add up to more than 100% because a single record can carry several classes.
Filings rose from 19 in 2017 to a peak of 31 in 2022, then eased. The three-year run from 2021 (5) to 2024 (11) is the clearest complete-year signal available — a 120% increase — and 2024 is the last year that should be read as a finished total; 2025 and 2026 are still filling in as publications catch up to filing dates.
C12P (fermentation and enzymatic synthesis) covers 81.8% of the 479 records, with C12M (bioreactors and apparatus) at 53.9% and C12N (microorganisms and genetic engineering) at 52.0% close behind — expected, given the search terms. Downstream separation hardware under B01D appears in only 8.1% of records, and food-application claims under A23L sit at 13.2%, both markers of thinner claim density outside the core fermentation step itself.
Shares are the percentage of the 479 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.
This page is one run against one query. Ask Eureka your own question about precision fermentation product recovery and every answer comes back with the patent numbers behind it.
Try EurekaThe filing covers a process and apparatus for capturing carbon by microbial fermentation, specifically directing waste gas streams containing CO and CO2 from a cupola furnace in a foundry setting into a gas fermentation process that converts the captured gas into one or more products.Filed by LanzaTech, whose affiliated entities occupy several of the leading positions in this ranking.

| # | Publication no. | Patent title | Citations |
|---|---|---|---|
| 1 | US6022725A | Cloning and amplification of the beta -glucosidase gene of Trichoderma reesei | 874 |
| 2 | WO1995012608A1 | Synthesizing and screening molecular diversity | 379 |
| 3 | US20060286205A1 | Biomass hydrolysate and uses and production thereof | 180 |
| 4 | US20100330633A1 | Integrated System and Process for Bioproduct Production | 176 |
| 5 | WO2006069610A2 | Process for the production of fine chemicals | 101 |
| 6 | US20150133636A1 | Purification of Biological Molecules | 97 |
| 7 | EP0562003A1 | IMPROVED SACCHARIFICATION OF CELLULOSE BY CLONING AND AMPLIFICATION OF THE $g(b)-GLUCOSIDASE GENE OF TRICHODE… | 80 |
| 8 | WO2018144965A1 | Microbial conversion of co 2 and other c1 substrates to vegan nutrients, fertilizers, biostimulants, and syst… | 77 |
| 9 | US8278261B2 | Method of making soaps from oil-bearing microbial biomass and oils | 69 |
| 10 | WO1996036706A1 | A method for large scale plasmid purification | 67 |
Citation counts reward older, foundational filings inside this corpus — they signal influence on later work, not current commercial importance. The oldest record here, on Trichoderma reesei beta-glucosidase cloning, has drawn far more citations than any recent filing simply by virtue of age.
Each row carries its publication number; clicking a row searches Eureka by that number.
When you want the answer in the next five minutes.
The agent works the prompt against patents and technical literature, citing every source.
Run your analysis now →When it has to run inside your own pipeline.
Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.
Browse MCP servers →Three patterns stand out once concentration, growth and technology mix are read together.
A single leader holds 43 records and the top five combined reach 150 records — 31.3% of everything in scope. The top ten extend that to 217 records, or 45.3%. Below that sits a long tail of single- and few-filing entrants, which is where most new applicants land.
Filings rose from 5 in 2021 to 11 in 2024, a 120% increase over the last three-year span that can be treated as complete. 2025 and 2026 show fewer filings only because publication trails filing by roughly 18 months, not because activity has slowed.
Core fermentation claims under C12P sit on 81.8% of records, but the physical separation step — filtration and comparable B01D processes — appears on only 8.1%. That gap suggests recovery-hardware claims are less crowded than the fermentation and organism claims layered on top of them.
The EPO recorded 100 filings in scope, ahead of the United States at 87, PCT (WIPO) at 45, Canada at 40, Australia at 36 and India at 21. That order is worth checking against a specific applicant's own filing footprint before assuming any one jurisdiction is the default venue.
Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to precision fermentation product recovery, with the prior art for and against each one.
The ranking covers 100 companies, counted by records, and is the complete set the data endpoint returns for this search — not a curated top-50 or top-100 list. A leader holding 43 records sits well ahead of a fifth-place total of 22 and a tenth-place total of 11, so the drop-off from first to tenth is steep before the tail flattens out.
The leading assignee's record count is roughly double the fifth-place total, and its affiliated entities also appear separately in the ranking, which understates its true combined footprint if read as one applicant.
From fifth place at 22 records to tenth place at 11, the field halves — a normal pattern where a handful of established players hold meaningful portfolios without approaching the leader's scale.
Ten co-assignee pairs appear in the data, the strongest being a four-record partnership between a biotech process developer and a university engineering department, with two other pairs each reaching three joint records.
| Assignee | Recent year | YoY |
|---|---|---|
| LanzaTech New Zealand Ltd | 0 | — |
| LanzaTech Inc | 0 | -100% |
| Sweetwater Energy Inc | 0 | — |
| Kiverdi Inc | 0 | -100% |
| Merck & Co Inc | 0 | — |
| OPX Biotechnologies Inc | 0 | — |
| Genencor International Inc | 0 | — |
| Apalta Patents OU | 0 | — |
The landscape above answers who leads and how dense the claim space is. Turning that into a filing or freedom-to-operate decision needs a closer read of specific claims.
The IPC breakdown shows where claim volume sits, but not whether a particular clarification or extraction method is actually blocked. A claim-level search against the leader's granted set is the next step before committing to a filing.
Explore claim coverage in EurekaSeveral top-ranked entries in this dataset belong to related corporate entities. Consolidating them gives a truer read of how much of the 31.3% top-five share sits with a single controlling group.
Run a portfolio consolidation in EurekaPublication lag means the most recent 18 months of activity are still incomplete in any dataset pulled today. Re-checking this landscape in two quarters will fill in the true 2025 total.
Set a filing alert in EurekaOne assignee leads with 43 records in this 479-record dataset, well ahead of the fifth-place holder at 22 records. The top five assignees combined account for 31.3% of all records in scope, and the top ten reach 45.3%. Several of the leading positions belong to affiliated entities of the same corporate group, so the effective concentration at the top is likely tighter than the raw ranking shows.
Filings grew from 5 in 2021 to 11 in 2024, a 120% increase over the last three-year span with complete data. The visible dip in 2025 and 2026 is an artefact of publication lag, which typically runs about 18 months behind filing date, not a genuine slowdown. The peak year so far is 2022 at 31 filings, and later complete-year totals should be judged against 2024's 11, not against that peak.
Core fermentation and enzymatic synthesis claims under IPC class C12P appear in 81.8% of the 479 records, with bioreactor and apparatus claims (C12M) at 53.9% and microorganism and genetic engineering claims (C12N) at 52.0%. Downstream separation-process claims under B01D, covering filtration and similar recovery hardware, appear in only 8.1% of records. That gap indicates the physical recovery step is claimed far less densely than the fermentation and organism steps that precede it.
The clearest gap sits in separation-process hardware: B01D-classified claims cover only 8.1% of the 479 records despite recovery being one of the two search anchors for this entire dataset. Specific sub-areas worth checking include continuous broth clarification equipment, solvent-based capture from dilute product streams, and membrane-based phase separation applied specifically to microbial fermentation products. A first claim in these areas would need to tie a specific separation mechanism to a fermentation product stream rather than claiming fermentation and separation as generic adjacent steps.
The European Patent Office recorded the most filings in scope at 100, ahead of the United States at 87 and the PCT route at 45. Canada, Australia and India follow at 40, 36 and 21 respectively. This spread suggests applicants in this space are pursuing broad multi-jurisdiction protection rather than concentrating on a single home market, which is consistent with fermentation-based products aiming at global commodity or ingredient markets.
Go past this page: query the whole precision fermentation product recovery corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.
Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.
Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.
Machine translation. Assignee and organisation names originally recorded in Chinese, Japanese or Korean have been rendered into English by an AI translation step so that the tables stay readable. These renderings are best-effort and may not match a company's registered English name; the original name is what the underlying patent record carries, and it is what any Eureka query launched from this page uses.